JP2023549441A5 - - Google Patents
Info
- Publication number
- JP2023549441A5 JP2023549441A5 JP2023552376A JP2023552376A JP2023549441A5 JP 2023549441 A5 JP2023549441 A5 JP 2023549441A5 JP 2023552376 A JP2023552376 A JP 2023552376A JP 2023552376 A JP2023552376 A JP 2023552376A JP 2023549441 A5 JP2023549441 A5 JP 2023549441A5
- Authority
- JP
- Japan
- Prior art keywords
- chimeric antigen
- antigen receptor
- seq
- cells
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020904256 | 2020-11-18 | ||
| AU2020904256A AU2020904256A0 (en) | 2020-11-18 | Chimeric Antigen Receptor T Cell and Method | |
| PCT/AU2021/051374 WO2022104424A1 (en) | 2020-11-18 | 2021-11-18 | Chimeric antigen receptor t cell and method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023549441A JP2023549441A (ja) | 2023-11-24 |
| JP2023549441A5 true JP2023549441A5 (https=) | 2024-11-25 |
Family
ID=81707894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023552376A Pending JP2023549441A (ja) | 2020-11-18 | 2021-11-18 | キメラ抗原受容体ｔ細胞および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240033356A1 (https=) |
| EP (1) | EP4247856A4 (https=) |
| JP (1) | JP2023549441A (https=) |
| KR (1) | KR20230118850A (https=) |
| CN (1) | CN116829161A (https=) |
| AU (1) | AU2021382173A1 (https=) |
| CA (1) | CA3202371A1 (https=) |
| IL (1) | IL303015A (https=) |
| WO (1) | WO2022104424A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025261427A1 (zh) * | 2024-06-20 | 2025-12-26 | 启光德健医药科技(苏州)有限公司 | 用于评估抗体免疫激动剂偶联物产生ada的方法及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR122020002986A8 (pt) * | 2012-08-20 | 2023-04-18 | Seattle Childrens Hospital Dba Seattle Childrens Res Inst | Método e composições para imunoterapia celular |
| CA2944649C (en) * | 2014-04-04 | 2022-06-21 | Bionomics, Inc. | Humanized antibodies that bind lgr5 |
| WO2017161414A1 (en) * | 2016-03-22 | 2017-09-28 | Bionomics Limited | Administration of an anti-lgr5 monoclonal antibody |
| AU2017335634A1 (en) * | 2016-09-27 | 2019-03-14 | Cero Therapeutics, Inc. | Chimeric engulfment receptor molecules |
| US20200114017A1 (en) * | 2017-06-16 | 2020-04-16 | Bionomics Limited | Antibody drug conjugates that bind lgr5 |
| EP4714966A2 (en) * | 2017-09-26 | 2026-03-25 | Cero Therapeutics Holdings, Inc. | Chimeric engulfment receptor molecules and methods of use |
| CA3093969A1 (en) * | 2018-03-28 | 2019-10-03 | Cero Therapeutics, Inc. | Expression vectors for chimeric engulfment receptors, genetically modified host cells, and uses thereof |
| MX2020010241A (es) * | 2018-03-28 | 2020-10-16 | Cero Therapeutics Inc | Composiciones de inmunoterapia celular y usos de las mismas. |
-
2021
- 2021-11-18 EP EP21893142.6A patent/EP4247856A4/en active Pending
- 2021-11-18 KR KR1020237019712A patent/KR20230118850A/ko active Pending
- 2021-11-18 CA CA3202371A patent/CA3202371A1/en active Pending
- 2021-11-18 JP JP2023552376A patent/JP2023549441A/ja active Pending
- 2021-11-18 WO PCT/AU2021/051374 patent/WO2022104424A1/en not_active Ceased
- 2021-11-18 CN CN202180084184.2A patent/CN116829161A/zh active Pending
- 2021-11-18 US US18/037,676 patent/US20240033356A1/en active Pending
- 2021-11-18 AU AU2021382173A patent/AU2021382173A1/en active Pending
- 2021-11-18 IL IL303015A patent/IL303015A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12343379B2 (en) | Interleukin-18 variants and methods of use | |
| AU2019218989B2 (en) | Chimeric antigen receptors targeting the tumor microenvironment | |
| US10774151B2 (en) | Anti-human 4-1BB antibodies and uses thereof | |
| JP7061235B2 (ja) | 抗ｃｌｄ１８ａ２ナノ抗体及びその応用 | |
| KR102520550B1 (ko) | Cd19 및 cd20을 표적화하는 조합된 키메라 항원 수용체 및 그의 적용 | |
| US20260078166A1 (en) | Anti-dll3 chimeric antigen receptors and uses thereof | |
| JP2024125370A (ja) | クローディン１８．２結合部分およびその利用 | |
| JP2024023318A (ja) | 二重特異性抗体の組成物及びその使用方法 | |
| US12600776B2 (en) | Anti-L1CAM antibody or antigen-binding fragment thereof and chimeric antigen receptor comprising same | |
| US20240374679A1 (en) | Interleukin-18 mimics and methods of use | |
| JP2021121201A (ja) | 前立腺特異幹細胞抗原に対する抗体およびその使用 | |
| JP2022542543A5 (https=) | ||
| JP2018521008A (ja) | 腫瘍形成を処置するための治療用組成物および治療方法 | |
| JP2024164118A (ja) | バリアントｃｄ８０融合タンパク質および関連構築物の方法および使用 | |
| CN115989033B (zh) | 用于使用cd70特异性融合蛋白进行tcr重编程的组合物和方法 | |
| CN109651511A (zh) | 一种靶向bcma的嵌合抗原受体及其应用 | |
| CN112689642A (zh) | 具有各种不同的构建物优化的t细胞抗原偶联物 | |
| CN113825772A (zh) | 抗her2亲合体及将其用作开关分子的可切换嵌合抗原受体 | |
| JP2023549441A5 (https=) | ||
| JP2022514815A (ja) | ＣＤＲ１領域に突然変異したヒト化ＣＤ１９ ｓｃＦｖを有するＣＡＲ－Ｔ細胞 | |
| TW202237633A (zh) | 嵌合受體及其使用方法 | |
| WO2024121297A1 (en) | A kit for use in the treatment of hematological cancer | |
| WO2024231348A1 (en) | Slc4a4/nbce1 inhibitors | |
| EA047760B1 (ru) | Группы, связывающие клаудин 18.2, и их использование | |
| NZ750420A (en) | Antibody for anti-claudin 18a2 and use thereof |